Ironwood Pharmaceuticals, Inc. (IRWD)
4.13
-0.16
(-3.73%)
USD |
NASDAQ |
Aug 24, 16:00
4.12
-0.01
(-0.24%)
After-Hours: 07:44
Ironwood Pharmaceuticals Market Cap : 682.44M for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 682.44M |
| August 21, 2026 | 708.88M |
| August 20, 2026 | 684.09M |
| August 19, 2026 | 720.45M |
| August 18, 2026 | 712.18M |
| August 17, 2026 | 720.45M |
| August 14, 2026 | 712.18M |
| August 13, 2026 | 674.18M |
| August 12, 2026 | 713.84M |
| August 11, 2026 | 710.53M |
| August 10, 2026 | 669.22M |
| August 07, 2026 | 713.84M |
| August 06, 2026 | 703.92M |
| August 05, 2026 | 685.75M |
| August 04, 2026 | 712.18M |
| August 03, 2026 | 727.59M |
| July 31, 2026 | 696.31M |
| July 30, 2026 | 614.01M |
| July 29, 2026 | 586.02M |
| July 28, 2026 | 625.53M |
| July 27, 2026 | 643.64M |
| July 24, 2026 | 610.72M |
| July 23, 2026 | 623.88M |
| July 22, 2026 | 638.70M |
| July 21, 2026 | 643.64M |
| Date | Value |
|---|---|
| July 20, 2026 | 633.76M |
| July 17, 2026 | 635.41M |
| July 16, 2026 | 637.05M |
| July 15, 2026 | 658.45M |
| July 14, 2026 | 655.16M |
| July 13, 2026 | 693.02M |
| July 10, 2026 | 735.82M |
| July 09, 2026 | 768.74M |
| July 08, 2026 | 785.21M |
| July 07, 2026 | 735.82M |
| July 06, 2026 | 721.01M |
| July 02, 2026 | 712.78M |
| July 01, 2026 | 678.21M |
| June 30, 2026 | 693.02M |
| June 29, 2026 | 707.84M |
| June 26, 2026 | 679.85M |
| June 25, 2026 | 632.12M |
| June 24, 2026 | 643.64M |
| June 23, 2026 | 635.41M |
| June 22, 2026 | 628.82M |
| June 18, 2026 | 582.73M |
| June 17, 2026 | 579.44M |
| June 16, 2026 | 602.48M |
| June 15, 2026 | 607.42M |
| June 12, 2026 | 600.84M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AbbVie, Inc. | 467.43B |
| Rigel Pharmaceuticals, Inc. | 841.48M |
| Marker Therapeutics, Inc. | 25.01M |
| Verastem, Inc. | 620.70M |
| Theriva Biologics, Inc. | 10.79M |
Market Cap Related Metrics
| PE Ratio | 5.386 |
| PS Ratio | 1.788 |
| Price to Free Cash Flow | 3.751 |
| Price | 4.13 |
| Earnings Yield | 18.57% |
| Operating PE Ratio | 2.948 |
| Normalized PE Ratio | 5.334 |